Alr Technologies Stock Price, News & Analysis
ALRTF
OTC
Company Description
ALR Technologies SG Ltd. (OTCQB: ALRTF) is a diabetes management company that has developed the ALRT Diabetes Solution, an FDA-cleared system for diabetes care. The system collects data from blood glucose meters and continuous glucose monitoring devices. The company's cornerstone is the Predictive A1c algorithm, which is designed to track treatment success and optimize diabetes drug therapies. The animal health division of ALRT has created the GluCurve Pet CGM to help veterinarians determine the efficacy of insulin treatments for companion animals. ALRT is dedicated to improving patient outcomes and providing innovative solutions for diabetes care.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$3.8M
Market Cap
635.5M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Alr Technologies.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Alr Technologies (ALRTF)?
The current stock price of Alr Technologies (ALRTF) is $0.003 as of May 8, 2025.
What is the market cap of Alr Technologies (ALRTF)?
The market cap of Alr Technologies (ALRTF) is approximately 3.8M.
What is ALR Technologies SG Ltd.?
ALRT is a diabetes management company that offers the ALRT Diabetes Solution and the GluCurve Pet CGM for companion animals.
What is the ALRT Diabetes Solution?
The ALRT Diabetes Solution is an FDA-cleared system that collects data from blood glucose meters and continuous glucose monitoring devices to optimize diabetes drug therapies.
What is the Predictive A1c algorithm?
The Predictive A1c algorithm is a key component of ALRT's system, designed to track treatment success and provide best practice guidelines for diabetes care.
What is the GluCurve Pet CGM?
The GluCurve Pet CGM is a solution developed by ALRT's animal health division to assist veterinarians in determining the efficacy of insulin treatments for companion animals.
What are the goals of ALR Technologies SG Ltd.?
ALRT aims to improve patient outcomes by offering innovative solutions for diabetes care and optimizing drug therapies for both humans and companion animals.
Who is Sidney Chan?
Sidney Chan is the Chairman and CEO of ALRT and the owner of the Predictive A1c algorithm. The company has an informal license with Mr. Chan and expects to acquire the intellectual property in the next 12 months.
What recent achievements has ALR Technologies SG Ltd. announced?
ALRT has recently obtained a patent for the Predictive A1c algorithm, granted in Singapore and with a notice of allowance in the United States. The company has also completed a successful 24-week study with Singapore General Hospital, demonstrating a 1.2 percent drop in mean glycated hemoglobin for patients using the ALRT Diabetes Solution.
How can investors contact ALR Technologies SG Ltd.?
For investor relations inquiries, contact ir@alrt.com. For animal health inquiries, reach out to animalhealth@alrt.com. Media inquiries can be directed to media@alrt.com. Phone numbers for the US and Singapore offices are provided for additional contact information.
What is the focus of ALR Technologies SG Ltd.'s animal health division?
The animal health division of ALRT is dedicated to developing solutions that optimize diabetic drug therapies for companion animals, such as the GluCurve Pet CGM.
What steps has ALR Technologies SG Ltd. taken to protect its intellectual property?
ALRT has pursued patent applications for the Predictive A1c algorithm in multiple jurisdictions, with plans to acquire the intellectual property in the near future. The company aims to secure its competitive advantage and protect its clinically proven effective diabetes management system.